Enquyst Technologies Inc
The startup develops biopharmaceutical technology that utilizes a chromatography-free, modular, and continuous process for monoclonal antibody production and viral vector separation. This approach significantly lowers capital and operating expenditures for biologics manufacturing plants, allowing biopharma companies to dynamically adjust production capacity.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$5.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops biopharmaceutical technology that utilizes a chromatography-free, modular, and continuous process for monoclonal antibody production and viral vector separation. This approach significantly lowers capital and operating expenditures for biologics manufacturing plants, allowing biopharma companies to dynamically adjust production capacity.